Multilevel Revision Percutaneous Vertebroplasty in Elderly Patients With Osteoporotic Thoracolumbar Fractures: A Retrospective Cohort Study Authors: Stylianos Kapetanakis, Mikail Chatzivasiliadis, Nikolaos Gkantsinikoudis, Krikor Gkoumousian, Panagiotis Konstantinou, Lazaros Kostretzis, Iosafat Pinto, Lazaros Poultsides, Paschalis Tsioulas, Konstantinos Ditsios Published: 2026 ABSTRACT ABSTRACTPurposeVertebral compression fractures (VCFs) are common complications of osteoporosis in elderly patients. Percutaneous vertebroplasty (PVP) provides pain relief and functional improvement, but some patients require revision due to refracture, cement failure, or new symptomatic levels. While outcomes of primary and multilevel augmentation have been described, systematic data on multilevel revision PVP remain rare. The aim of this study was to evaluate pain relief, functional improvement, and perioperative safety after three‐ and four‐level revision PVP in elderly patients with osteoporotic thoracolumbar fractures.MethodsThis retrospective, single‐center cohort included patients aged 75–85 years who underwent revision PVP between August 2019 and November 2023. Eligible cases had a history of prior PVP and required repeat augmentation of three or four vertebral levels in a single session. Visual Analogue Scale (VAS) scores for pain and Oswestry Disability Index (ODI) for functional disability were recorded preoperatively and at 1‐, 3‐, 6‐, and 12‐month follow‐up.ResultsNine patients were analyzed. Revision involved three levels in five patients and four levels in four patients, with a mean interval of 14.1 months after the index procedure. Mean VAS improved from 8.3 ± 0.7 preoperatively to 3.2 ± 0.6 at 12 months (61% reduction, p < 0.01). ODI improved from 75.2% ± 3.4% to 26.9% ± 2.7% (64% reduction, p < 0.01). All patients exceeded the minimal clinically important difference thresholds. No perioperative complications such as cement leakage, neurological deficits, or pulmonary events were observed.ConclusionThree‐ and four‐level revision PVP provided significant pain relief and functional improvement in elderly patients with osteoporotic fractures, without increased complication rates. To our knowledge, this represents one of the first reports addressing this topic, suggesting it is an effective option in carefully selected patients. Introduction Vertebral compression fractures (VCFs) are the most common complications of osteoporosis, especially in the elderly population [1]. Over 750,000 vertebral fractures are reported annually in the United States alone, which is similar to the incidence rates seen across Europe [2]. Epidemiological studies have reported that around 20% of individuals over the age of 70 will experience at least one vertebral fracture in their lifetime [3]. Besides pain and mortality risk, VCFs are also associated with impaired mobility, decreased quality of life, and a higher risk of future fractures. These consequences are not limited to the patient alone, as they also increase the demands in healthcare and social support systems. Conservative treatment of VCFs, such as bed rest, analgesics, and bracing, is usually chosen as initial management [4]. However, in many patients, this unfortunately fails to give sufficient pain relief or functional recovery. In such cases, an effective alternative is minimally invasive procedures such as percutaneous vertebroplasty (PVP), especially in patients with persistent symptoms [5, 6]. This procedure offers to restore the vertebral body height and correct spinal alignment, as well as relief of pain [5, 6]. Due to the growing use of PVP procedures and its minimally invasive nature, its use has extended beyond single‐level fractures to include multilevel procedures [7]. Despite generally favorable outcomes, some patients require revision surgery after PVP due to persistent pain, progressive collapse of the treated vertebra, cement failure, or new adjacent‐level fractures [8]. Revision procedures are technically demanding, and the optimal approach in fragile, elderly patients remains uncertain. Published revision series are limited, and data on outcomes after multilevel revision augmentation are particularly scarce. The purpose of this study is to assess pain reduction using the visual analogue scale (VAS) and functional improvement using the Oswestry Disability Index (ODI) in patients undergoing three‐ and four‐level revision PVP. By focusing on revision cases, this study aims to clarify the role of multilevel augmentation in a high‐risk population where treatment options are often limited. Materials and Methods Study Design and Setting This was a retrospective, single‐center cohort study conducted at our outpatient clinic between August 2019 and November 2023. All procedures were performed as part of routine clinical care by a single spine surgeon. The study was approved by the Ethics Committee of the European Interbalkan Medical Center (Approval No. 1712/13.04.2022) and carried out in accordance with the principles of the Declaration of Helsinki. It was designed as a retrospective chart review, using data routinely collected during standard clinical care. All patients had provided informed consent for the procedure and the subsequent use of anonymized clinical data for research purposes. Patient Selection Eligible patients were identified through operative records and imaging databases. Patients were included if they were between 75 and 85 years of age, had a diagnosis of osteoporotic vertebral compression refractures confirmed with magnetic resonance imaging (MRI), and had a history of prior PVP. All included patients had DXA‐confirmed osteoporosis and were receiving pharmacologic anti‐osteoporotic therapy with bisphosphonates in combination with vitamin D supplementation at the time of revision or initiated immediately postoperatively. In addition, only those who underwent revision PVP involving three or four vertebral levels in a single session were considered eligible. Additional criteria required that patients presented with subacute or chronic back pain lasting more than 4 weeks, corresponding to vertebral fractures in which balloon reduction was not feasible due to early reparative changes of the vertebral body. Furthermore, a minimum clinical follow‐up of 12 months was required, with available VAS and ODI data at baseline and follow‐up. Patients were excluded if they fell outside the specified age range, underwent revision procedures for neoplastic, traumatic, or infectious vertebral fractures, or required emergency decompression for neurological complications following the initial procedure. Patients with incomplete clinical records or missing VAS and ODI data were also excluded. Definition of Revision For the purposes of this study, revision PVP was defined as repeat vertebral augmentation performed primarily at previously treated vertebral levels due to symptomatic refracture or failure of the index procedure. Concomitant treatment of an adjacent‐level fracture during the same revision session was permitted when clinically indicated. Surgical Technique Preoperative planning included review of standing radiographs and MRI to confirm the symptomatic revision levels and assess fracture morphology, posterior wall integrity, and the distribution of previously injected cement. Particular attention was given to residual unfilled areas, intravertebral clefts, cortical defects, and potential routes of cement leakage. Coagulation status and relevant cardiopulmonary comorbidities were reviewed preoperatively because of the advanced age and frailty of the cohort. All procedures were performed by the same experienced spine surgeon under fluoroscopic guidance. Patients were positioned prone on a radiolucent table, and the target vertebrae were localized using anteroposterior and lateral fluoroscopy. A transpedicular approach was used in all cases. In revision levels, the cannula trajectory was planned according to the location of the previous cement, with the aim of reaching residual non‐augmented or insufficiently supported areas of the vertebral body while avoiding the posterior wall and cortical breaches. Balloon tamps were not employed, as all cases involved subacute or chronic fractures with partial healing, in which cavity creation was not considered feasible. Polymethylmethacrylate bone cement was prepared according to the manufacturer's instructions and injected during the high‐viscosity phase. Cement was applied slowly and incrementally under continuous lateral fluoroscopy with repeated anteroposterior checks. Injection was stopped if cement approached the posterior vertebral wall, entered the venous plexus, extended toward the neural foramen or spinal canal, or showed any extraosseous leakage. Cement volume was individualized according to vertebral body size, fracture morphology, and the amount and distribution of previous cement. Final fluoroscopic images were obtained to confirm cement distribution and exclude clinically relevant leakage. Representative imaging is provided in Figure 1. Preoperative and intraoperative imaging of four‐level revision PVP. (A) Sagittal T2‐weighted MRI of the thoracolumbar spine demonstrating osteoporotic vertebral compression fractures at T11, L1, L2, and L3. (B, C) Intraoperative fluoroscopic guidance showing transpedicular cannula placement for cement augmentation. Vertebral levels are labeled for clarity. Data Collection Data collected included demographic characteristics such as age and sex, as well as surgical details including the initial and revision levels, the number of levels treated, the contiguity pattern, and the interval between the index procedure and the revision. Information on bone health status was recorded where available, including documentation of DXA‐confirmed osteoporosis and the use of pharmacologic anti‐osteoporotic therapy with bisphosphonates and vitamin D supplementation. Clinical outcomes were evaluated with the VAS for pain and the ODI for functional disability [9, 10]. Assessments were performed preoperatively and at 1‐, 3‐, 6‐, and 12‐month follow‐up. VAS and ODI scores were obtained in clinic through personal interview with the patients, conducted by the same surgeon at each follow‐up. Procedural complications, including cement leakage, new neurological deficits, and pulmonary events, were also monitored. Statistical Analysis Because the study included only a small number of revision patients, the data was mainly described using basic summary statistics rather than complex analyses. Continuous variables are presented as mean values with standard deviations (SD) and ranges, and categorical variables are expressed as absolute numbers and percentages. Changes in VAS and ODI between baseline and follow‐up were analyzed with the Wilcoxon signed‐rank test, and comparisons between patients undergoing three‐ versus four‐level revision procedures were performed using the Mann–Whitney U test. A p value of less than 0.05 was considered statistically significant. All statistical analyses were performed using IBM SPSS Statistics version 26.0 (IBM Corp., Armonk, NY, USA). Results Patient Demographics and Surgical Characteristics A total of nine patients were included in the analysis, with a mean age of 79.9 ± 3.4 years (range, 75–85). The cohort consisted of five males (55.6%) and four females (44.4%), and all patients presented with kyphotic deformity secondary to the osteoporotic vertebral compression fractures. Eight patients underwent revision exclusively at previously treated vertebral levels, while one patient had a concomitant adjacent‐level fracture treated during the same revision session. The mean time from the index procedure to revision was 14.1 ± 2.0 months (range, 12–18). Revision procedures involved three vertebral levels in five patients (55.6%) and four levels in four patients (44.4%). Most were performed across contiguous vertebrae (n = 6), with three patients undergoing a skip‐level revision. Clinical follow‐up was added in all nine patients after 12 months. Baseline demographic and surgical characteristics of the cohort are summarized in Table 1. Representative intraoperative and postoperative views of three‐ and four‐ level revision procedures are shown in Figures 2 and 3. TABLE 1Baseline demographic and surgical characteristics of patients undergoing revision PVP.PatientAge (years)SexNumber of levels treated in revisionTime from index to revision (months)KyphosisContiguity175M312YesSkip‐level277F414YesSkip‐level377M316YesContiguous478M413YesSkip‐level580F313YesContiguous681M318YesContiguous782F412YesContiguous884M415YesContiguous985F314YesSkip‐level Baseline demographic and surgical characteristics of patients undergoing revision PVP. Intraoperative views of revision PVP. Examples of three‐level revision procedures are shown, with multiple transpedicular cannulas in place for cement augmentation under fluoroscopic guidance. Postoperative coronal radiographs following three‐ and four‐level revision PVP. (A) L2–L4 three‐level revision showing satisfactory cement distribution across the treated vertebrae. (B) T11, L2, L3, and L4 four‐level revision. Areas of previous augmentation remain visible as irregular cement deposits of varying density, in contrast to the more homogeneous and well‐contoured cement filling achieved during the revision procedures. Pain Outcomes Pain outcomes improved significantly. Mean VAS decreased from 8.3 ± 0.7 at baseline to 4.2 ± 0.7 at 1 month, 3.7 ± 0.8 at 3 months, and 3.4 ± 0.5 at 6 months, with sustained relief at 12 months (3.2 ± 0.6). The greatest benefit was achieved within the first three to 6 months and remained fairly stable afterwards. VAS scores improved significantly from baseline to all follow‐up intervals (p < 0.01). Mean improvement at 12 months was −5.1 points, which corresponds to an approximate 61% pain reduction. Individual improvements ranged from 3 to 7 points, and all patients achieved a clinically meaningful reduction of at least 2 points. However, no significant differences were observed between 3‐level and 4‐level (p = 0.79). Functional Outcomes Functional outcomes showed a similar pattern. ODI scores decreased significantly from baseline to all follow‐up intervals (p < 0.01). The mean ODI improved from 75.2% ± 3.4% at baseline to 26.9% ± 2.7% at 12 months, which corresponds to a relative reduction of approximately 48 points (~64%). The greatest improvement was noted within the first 3 months (mean 30.4% ± 2.4%), after which disability scores remained stable with only minor additional improvements through 12 months. Individual ODI improvements ranged from 38 to 52 percentage points, and all patients greatly exceeded the minimal clinically important difference threshold of 15 points. No significant difference in functional improvement was observed between three‐level and four‐level revision (p = 0.89). Summary statistics for VAS and ODI scores at baseline and follow‐up are shown in Table 2. Figures 4 and 5 demonstrate the course of clinical improvement, with VAS scores decreasing significantly within the first month and ODI values showing parallel functional gains, both of which were sustained at 12 months. TABLE 2Summary statistics for VAS and ODI scores at baseline and follow‐up. Values are presented as mean and SD.MeasureMeanSD p VASPreop8.330.71—1 months4.220.67< 0.013 months3.720.80< 0.016 months3.390.50< 0.0112 months3.220.67< 0.01ODIPreop75.223.35—1 months40.672.65< 0.013 months30.442.30< 0.016 months29.002.24< 0.0112 months26.892.67< 0.01 Note: Paired comparisons with baseline demonstrate statistically significant improvements at all postoperative time points (p < 0.01). p values indicate comparisons with preoperative values.Abbreviations: ODI, Oswestry Disability Index; Preop, preoperative; SD, standard deviation; VAS, Visual Analogue Scale. Summary statistics for VAS and ODI scores at baseline and follow‐up. Values are presented as mean and SD. Note: Paired comparisons with baseline demonstrate statistically significant improvements at all postoperative time points (p < 0.01). p values indicate comparisons with preoperative values. Abbreviations: ODI, Oswestry Disability Index; Preop, preoperative; SD, standard deviation; VAS, Visual Analogue Scale. Mean VAS scores ± SD at baseline and follow‐up (preoperative, 1, 3, 6, and 12 months). Significant improvement was observed from baseline to all postoperative time points (p < 0.001). Mean ODI scores ± SD at baseline and follow‐up (preoperative, 1, 3, 6, and 12 months). Functional disability improved significantly from baseline to all postoperative time points (p < 0.001), with the greatest benefit achieved within the first 3–6 months and maintained at 12 months. Radiographic Findings and Complications Postoperative radiographs demonstrated no improvement in kyphotic alignment, which can be attributed to the absence of balloon‐assisted reduction during the procedure. No perioperative complications were reported. Specifically, there were no cases of cement leakage, new neurological deficits, or pulmonary events, and no patients required additional delayed vertebral augmentation during the follow‐up period. Discussion Main Findings This study demonstrated that three‐ and four‐level revision PVP was associated with significant and sustained improvement in pain and functional disability in elderly patients with osteoporotic thoracolumbar fractures. Mean VAS improved from 8.3 preoperatively to 3.2 at 12 months, while ODI improved from 75.2% to 26.9% over the same period. Importantly, no statistically significant differences were observed between the three‐level and four‐level cohorts across the evaluated parameters, which possibly indicates that the inclusion of a fourth level did not compromise the efficacy of the revision procedures. No perioperative complications, including cement leakage, neurological deterioration, or pulmonary events, were observed. The results suggest that multilevel PVP revisions can be safe and effective when performed under controlled conditions, even at the upper end of three to four treated vertebral levels. The decision to approach the revision with fusion was not considered in this cohort, even though fusion procedures are sometimes employed as a revision strategy after PVP. Given the patients' advanced age and the invasive nature of fusion, repeat vertebroplasty was deemed the safer and more appropriate option. Fusion usually comes with increased risks of high blood loss, longer operative time, and perioperative complications, which would be poorly tolerated in very elderly and frail patients [11]. Clinical and Technical Considerations The consistency of outcomes between three and four level revisions is likely a reflection of the standardized perioperative protocols, and the accumulated experience of the treating surgeon. All procedures were performed by a single spine surgeon with 15 years of experience in spine surgery, which may have reduced technical variability and contributed to the safe performance of these multilevel revision procedures. These factors collectively reduced the variability in the outcomes and lowered the risks associated with multilevel augmentation. This suggests that multilevel PVP does not necessarily mean that there are worse outcomes. Patient selection may also have played an important role, as all included patients were elderly patients over the age of 75 with symptomatic vertebral fractures. According to gerontological classifications, patients aged 75 years and older are considered to be in the ‘fourth age,’ reflecting a stage of advanced aging characterized by increased vulnerability and frailty [12]. In our cohort, kyphotic alignment was not given any emphasis because balloon‐assisted reduction was not used; however, this did not compromise the clinical outcomes. Previous studies have shown that although kyphoplasty can achieve greater restoration of vertebral height and correction of local kyphosis compared to vertebroplasty, these radiographic improvements do not consistently lead to better pain relief [13, 14]. Pain reduction is often independent of changes in vertebral height or alignment [13, 14]. While correcting kyphosis may help with overall sagittal balance in certain patients, this effect does not appear to directly influence symptom improvement. Emerging clinical evidence highlights that systemic skeletal fragility, rather than local biomechanical changes, is the predominant driver of refractures. Yang et al. reported that low bone mineral density and advanced age were the predictors of refracture after vertebroplasty, while cement volume and number of treated levels were not significant [15]. Similarly, Dai et al. concluded in a large meta‐analysis that patient factors like osteoporosis, female sex, and prior fracture history were far stronger factors that increased fracture risk [16]. These studies suggest that while early biomechanical models raise important concerns regarding the use of PVP in multiple levels, clinical outcomes over the past decade start supporting systemic fragility as a decisive factor in fracture recurrence. Our patient cohort that was treated with three‐ and four‐level revision procedures shows that it is of utmost importance that bone health is optimized next to the technical aspect. In the present cohort, all patients had DXA‐confirmed osteoporosis and were receiving pharmacologic anti‐osteoporotic therapy with bisphosphonates in combination with vitamin D supplementation at the time of revision or initiated immediately postoperatively. Despite standardized osteoporosis treatment, these patients sustained refractures requiring revision, underscoring the severity of systemic skeletal fragility in this population. This finding supports the concept that revision PVP primarily addresses pain and mechanical instability rather than modifying the underlying disease process. Consequently, vertebral augmentation should be regarded as an adjunct to, rather than a substitute for, comprehensive osteoporosis management, particularly in elderly patients with a high fracture burden. Evidence and Controversies in Vertebroplasty Another big point of controversy that needs to be discussed is the very efficacy of vertebroplasty itself, which was studied in the VERTOS IV trial [17]. Early randomized controlled trials started this debate when they reported that there was no significant advantage of PVP over placebo in terms of functional outcomes [18, 19]. After the publication of these studies, the VERTOS II and VAPOR trials demonstrated that vertebroplasty did offer clinically meaningful pain reduction and functional improvement when performed in patients with acute, MRI‐confirmed fractures and severe pain [20, 21]. Nonetheless, the VERTOS IV trial by Firanescu et al. again found no significant difference in pain relief or functional outcomes between PVP and sham procedures in patients with acute osteoporotic fractures [17]. However, our study differs in both scope and population. Even while we accept that VERTOS IV found no additional benefit of vertebroplasty over sham in single‐level to three‐level acute fractures, our study addresses a very different clinical scenario. It included extremely fragile, elderly patients with three‐ and four‐level vertebral refractures. In this population, where the fracture burden is high and conservative management often fails, PVP not only provided pain reduction but also restoration of mobility and independence. These differences in patient selection, fracture extent, revision, and outcome measures may explain why our results diverge from those of VERTOS IV [17]. Comparison With Multilevel and Revision Vertebroplasty Literature Furthermore, previous reports have documented multilevel vertebroplasty with more than three levels with acceptable outcomes, but they also highlighted increased risks such as cement leakage and complications. For example, Zidan et al. prospectively performed multilevel percutaneous vertebroplasty in 40 patients with osteoporotic fractures involving more than three levels and reported pain improvement to be at 90% while having low complication rates. In their study, 25% of patients underwent six level PVP [7]. Additionally, a retrospective series by Hekimoğlu et al. studied single‐session multilevel vertebroplasty and kyphoplasty in over three levels and found significant pain relief without a high incidence of major complications [22]. Cement leakage rates were reported in 18% of patients [22]. These outcomes suggest that carefully performed multilevel PVP in elderly patients can balance safety and benefit while avoiding the higher risks seen in more extensive interventions. Nonetheless, these studies did not include repeat fractures or revision procedures. When focusing specifically on repeat fractures or revision cases, only a few studies stand out. Previous reports of repeat vertebroplasty have largely been limited to small single‐level case series or isolated case reports. Gaughen et al. described six patients who underwent repeat PVP at previously treated levels with substantial pain relief in most cases, while Kim et al. similarly reported favorable outcomes in 10 patients requiring re‐augmentation due to persistent symptoms after the initial procedure [23, 24]. In both series, the revisions were performed at single vertebral levels instead of multiple segments. Chiu et al. performed a study with an 18‐patient cohort and demonstrated that repeat PVP was effective for symptomatic cemented vertebrae regardless of whether the underlying mechanism was refracture, residual vacuum clefts, or osteonecrosis [25]. Choi et al. highlighted in a case report that insufficient cement filling may predispose to refractures which need re‐augmentation [26]. In contrast to these prior experiences, our study focuses exclusively on elderly patients undergoing three‐ and four‐level revision PVPs, which have not been reported yet in the literature. Limitations and Strengths This study has several limitations that should be acknowledged. First, the retrospective design and small sample size limit the generalizability of the findings, although they also reflect the relative rarity of multilevel revision PVP in very elderly patients. As a result, the study is underpowered to detect small differences between subgroups, and the absence of statistically significant differences between three‐ and four‐level revision procedures should be interpreted with caution, as these comparisons were exploratory and subject to a potential Type II error. Second, subgroup analysis according to revision mechanism was not feasible because only one patient underwent concomitant adjacent‐level fracture treatment. Furthermore, no conservatively treated control group was available, which prevents a direct comparison between revision PVP and non‐surgical management. However, prolonged conservative treatment was often not clinically feasible in this highly symptomatic and frail population. Despite these limitations, the study has several strengths, including its focus on a rare and clinically challenging revision scenario, the inclusion of a homogeneous elderly cohort, and the availability of complete 12‐month clinical follow‐up using both VAS and ODI. The consistency and magnitude of clinical improvement observed across the cohort suggest that multilevel revision PVP may provide meaningful symptom relief in carefully selected elderly patients. Larger prospective and multicenter studies are needed to confirm these findings and to better define the role of multilevel revision vertebral augmentation in this population. Conclusion In this small retrospective cohort, three‐ and four‐level revision PVP was associated with sustained pain relief and functional improvement in elderly patients with osteoporotic thoracolumbar fractures, without perioperative complications or the need for additional delayed augmentation during follow‐up. These findings suggest that multilevel revision PVP may be a useful treatment option in carefully selected patients who are poor candidates for more invasive revision procedures. However, larger prospective multicenter studies are needed to validate these findings, better define the safety profile of four‐level augmentation, and identify which patients benefit most from this approach. In addition, PVP should be combined with systematic osteoporosis management programs that could help reduce refracture rates and optimize long‐term outcomes. Author Contributions Stylianos Kapetanakis: conceptualization, methodology, resources, writing – review and editing, visualization, supervision. Mikail Chatzivasiliadis: writing – original draft, conceptualization, methodology, formal analysis, writing – review and editing, visualization. Krikor Gkoumousian: investigation, writing – review and editing. Iosafat Pinto: writing – review and editing, investigation. Paschalis Tsioulas: writing – review and editing, investigation. Lazaros Kostretzis: investigation, writing – review and editing. Nikolaos Gkantsinikoudis: methodology, formal analysis, writing – review and editing. Lazaros Poultsides: investigation, writing – review and editing. Panagiotis Konstantinou: investigation, writing – review and editing. Konstantinos Ditsios: resources, writing – review and editing, supervision. Funding The authors have nothing to report. Ethics Statement This study was approved by the Ethics Committee of the European Interbalkan Medical Center (Approval No. 1712/13.04.2022). Written informed consent for participation was obtained from all patients. Consent Written informed consent was obtained from the patient and the parents for publication of this study and any accompanying images. Conflicts of Interest The authors declare no conflicts of interest.